Clincosm LogoSign in Get a demo

Biliary Tract Cancer

Showing 26 - 50 of 152
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer Trial in Worldwide (M7824)

Completed
Has Results
  • Biliary Tract Cancer
  • +2 more
  • Scottsdale, Arizona
  • +32 more
Oct 21, 2022

Advanced Solid Tumors, Colorectal Cancer, Non Small Cell Lung Cancer Trial in France, Spain (CAN04 (nadunolimab), mFOLFOX, DTX)

Active, not recruiting
  • Advanced Solid Tumors
  • +3 more
  • CAN04 (nadunolimab)
  • +3 more
  • Saint-Herblain, Boulevard Jacques Monod, France
  • +5 more
Oct 20, 2022

Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer Trial in Worldwide (Ramucirumab, Merestinib, Cisplatin)

Active, not recruiting
Has Results
  • Biliary Tract Cancer
  • +2 more
  • Tucson, Arizona
  • +91 more
Oct 18, 2022

Biliary Tract Cancer Trial in United States (Nivolumab, Nanoliposomal-Irinotecan, 5-Fluorouracil)

Active, not recruiting
  • Biliary Tract Cancer
  • Ann Arbor, Michigan
  • +4 more
Oct 6, 2022

Incidental Gallbladder Carcinoma, Biliary Tract Cancer Trial in Frankfurt (Gemcitabine, Cisplatin, Oncologically radical

Recruiting
  • Incidental Gallbladder Carcinoma
  • Biliary Tract Cancer
  • Frankfurt, Germany
    Krankenhaus Nordwest gGmbH
Sep 7, 2022

Solid Tumor, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Canada, Spain, United States (BNT141,

Recruiting
  • Solid Tumor
  • +7 more
  • BNT141
  • +2 more
  • Duarte, California
  • +10 more
Aug 23, 2022

Pancreatic Tumors, Solid Tumors, Biliary Tract Cancer Trial (BI 907828)

Not yet recruiting
  • Pancreatic Neoplasms
  • +2 more
  • BI 907828
  • (no location specified)
Aug 22, 2022

Biliary Tract Cancer Trial in Changchun (Lenvatinib, PD-1 inhibitors)

Recruiting
  • Biliary Tract Cancer
  • Changchun, Jilin, China
    Liu Bo
Aug 18, 2022

Gastric Adenocarcinoma, Adenocarcinoma of the Gastroesophageal Junction, NSCLC Trial in Worldwide (Ramucirumab, Pembrolizumab)

Completed
  • Gastric Adenocarcinoma
  • +4 more
  • New Haven, Connecticut
  • +21 more
Aug 17, 2022

Biliary Tract Cancer, Cholangiocarcinoma, Gall Bladder Cancer Trial (CTX-009, Paclitaxel)

Not yet recruiting
  • Biliary Tract Cancer
  • +3 more
  • (no location specified)
Aug 16, 2022

Incidental Gallbladder Carcinoma-Permanent Platform Including

Recruiting
  • Biliary Tract Cancer
  • Neoadjuvant, Adjuvant and 1st Line
    • Frankfurt, Germany
      Krankenhaus Nordwest GmbH
    Aug 3, 2022

    Gemcitabine, Biliary Tract Cancer, Immune Checkpoint Inhibitors Trial in Hangzhou (Gemcitabine-based chemo regimen combined with

    Not yet recruiting
    • Gemcitabine
    • +2 more
    • Gemcitabine-based chemotherapy regimen combined with immunocheckpoint inhibitors
    • Hangzhou, Zhejiang, China
      Hangzhou First People's Hospital
    Aug 2, 2022

    Biliary Tract Cancer, Cholangiocarcinoma, Biliary Tract Tumors Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL))

    Recruiting
    • Biliary Tract Cancer
    • +2 more
    • Tumor Infiltrating Lymphocytes (TIL)
    • Pittsburgh, Pennsylvania
      Allyson Welsch
    Jul 21, 2022

    Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer Trial in Germany, Spain, United Kingdom (Pembrolizumab, Cisplatin,

    Active, not recruiting
    • Biliary Tract Cancer
    • +3 more
    • Leipzig, Germany
    • +6 more
    Jul 1, 2022

    Biliary Tract Cancer Trial in Goyang-si, Seoul (SMT-NK inj.+Pembrolizumab, Pembrolizumab)

    Recruiting
    • Biliary Tract Cancer
    • Goyang-si, Gyeonggi-do, Korea, Republic of
    • +2 more
    Jun 28, 2022

    Biliary Tract Cancer Trial in Seoul (Pemetrexed 500 MG, Erlotinib)

    Recruiting
    • Biliary Tract Cancer
    • Seoul, Korea, Republic of
    • +1 more
    Jun 13, 2022

    Biliary Tract Cancer Trial (RC48-ADC, Envafolimab)

    Not yet recruiting
    • Biliary Tract Cancer
    • (no location specified)
    Jun 9, 2022

    Hepatobiliary Tumors Tissue Samples Acquisition

    Recruiting
    • Hepatocellular Carcinoma
    • +7 more
    • Gene expression analysis
    • +10 more
    • Beijing, Beijing, China
      Chinese Academy of Medical Sciences & Peking Union Medical Colle
    Jun 8, 2022

    Biliary Tract Cancer, Cholangiocarcinoma Trial in Aachen, Frankfurt (Bintrafusp alfa)

    Terminated
    • Biliary Tract Cancer
    • Cholangiocarcinoma
    • Bintrafusp alfa
    • Aachen, Germany
    • +1 more
    May 17, 2022

    Biliary Tract Cancer Trial in China (PT-112)

    Recruiting
    • Biliary Tract Cancer
    • Wuhan, Hubei, China
    • +3 more
    Apr 25, 2022

    Thyroid, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (SO-C101, pembrolizumab)

    Recruiting
    • Thyroid
    • +18 more
    • New Haven, Connecticut
    • +6 more
    Apr 8, 2022

    Pancreatic Cancer, Biliary Tract Cancer Trial in Beijing (Durvalumab, Lenvatinib, Nab paclitaxel)

    Recruiting
    • Pancreatic Cancer
    • Biliary Tract Cancer
    • Beijing, Beijing, China
      Biotherapeutic Department of Chinese PLA General Hospital
    Apr 7, 2022

    Biliary Tract Cancer Trial in Philadelphia (XmAb20717)

    Recruiting
    • Biliary Tract Cancer
    • Philadelphia, Pennsylvania
      Abramson Cancer Center at University of Pennsylvania
    Apr 11, 2022

    Biliary Tract Cancer, DNA Damage Repair Deficiency Trial in Seoul (Durvalumab, Olaparib)

    Recruiting
    • Biliary Tract Cancer
    • DNA Damage Repair Deficiency
    • Seoul, Korea, Republic of
      Asan Medical Center
    Apr 8, 2022

    Pancreatic Cancer, Biliary Tract Cancer Trial in Oslo, Stockholm (Physical exercise)

    Recruiting
    • Pancreatic Cancer
    • Biliary Tract Cancer
    • Physical exercise
    • Oslo, Norway
    • +1 more
    Mar 30, 2022